Immunomedics Inc (IMMU.OQ)

IMMU.OQ on NASDAQ Stock Exchange Global Market

3.71USD
27 Jul 2015
Change (% chg)

-- (--)
Prev Close
$3.71
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
255,619
52-wk High
$5.48
52-wk Low
$3.14

IMMU.OQ

Chart for IMMU.OQ

About

Immunomedics, Inc. is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders and other serious diseases. Using its technologies, the Company has built a pipeline of nine clinical-stage product candidates. Its advanced product candidate... (more)

Overall

Beta: 0.73
Market Cap(Mil.): $346.75
Shares Outstanding(Mil.): 93.46
Dividend: --
Yield (%): --

Financials

  IMMU.OQ Industry Sector
P/E (TTM): -- 447.82 40.75
EPS (TTM): -0.51 -- --
ROI: -75.90 -5.59 15.62
ROE: -366.95 -5.45 16.71
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks